Brief: Creso Pharma Posts FY Unaudited Revenue Of A$9 Million, Up 44%
Jan 31 (Reuters) - Creso Pharma Ltd CPH.AX :
* FY2022 UNAUDITED REVENUE A$9 MILLION, UP 44%
Source text for Eikon: ID:nASX114GZb
Further company coverage: CPH.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Melodiol Global Health
See all newsBrief: Melodiol Global Health Reports Q1 Fy24 Unaudited Revenue Of A$4.8M
Brief: Melodiol Global Health Posts Group Unaudited H1 2024 Revenues Of A$9.3 Mln, Up 33%
Brief: Melodiol Global Health Seeks Trading Halt
Melodiol Global Health gains most in over 7 weeks on Canada asset sale
Brief: Melodiol Global Health Proposes A$12M Cash Asset Sale